{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Orlando&page=18&state=Florida", "query": { "state": "Florida", "city": "Orlando", "page": 18 }, "page_size": 10 }, "pagination": { "page": 18, "page_size": 10, "total_count": 1510, "total_pages": 151, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Orlando&page=19&state=Florida&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Orlando&page=17&state=Florida&page_size=10" }, "source": "local", "last_synced_at": "2026-10-29T10:47:16.274Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06628908", "title": "Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetic Peripheral Neuropathic Pain" ], "interventions": [ { "name": "Placebo (matched to Pregabalin)", "type": "DRUG" }, { "name": "Placebo (matched to SUZ)", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Suzetrigine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vertex Pharmaceuticals Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 1100, "start_date": "2024-10-01", "completion_date": "2027-05-31", "has_results": false, "last_update_posted_date": "2026-10-15", "last_synced_at": "2026-10-16T17:14:54.569Z", "location_count": 76, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Daphne, Alabama + 68 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Daphne", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06628908" }, { "nct_id": "NCT06452277", "title": "A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Advanced Non-small Cell Lung Cancer, HER2 Mutation" ], "interventions": [ { "name": "Carboplatin", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Pembrolizumab", "type": "DRUG" }, { "name": "Pemetrexed", "type": "DRUG" }, { "name": "Sevabertinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 444, "start_date": "2024-08-28", "completion_date": "2029-06-27", "has_results": false, "last_update_posted_date": "2026-10-15", "last_synced_at": "2026-10-28T02:41:38.703Z", "location_count": 25, "location_summary": "Newport Beach, California • San Diego, California • San Francisco, California + 20 more", "locations": [ { "city": "Newport Beach", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Fort Lauderdale", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06452277" }, { "nct_id": "NCT06215716", "title": "A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "MASH With Fibrosis", "NASH With Fibrosis" ], "interventions": [ { "name": "Efruxifermin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Akero Therapeutics, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 1650, "start_date": "2023-12-01", "completion_date": "2033-02", "has_results": false, "last_update_posted_date": "2026-10-15", "last_synced_at": "2026-10-28T11:11:00.436Z", "location_count": 198, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Chandler, Arizona + 160 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Flagstaff", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06215716" }, { "nct_id": "NCT05852457", "title": "Evaluation of the Clinical Utility of Endoscopic Closure Using a Dual Action Tissue (DAT) Clip", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Fistula", "GI Bleeding", "Perforated Bowel", "Perforation Bowel", "Perforation Colon", "Perforation Duodenal" ], "interventions": [ { "name": "DAT Clip", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "AdventHealth", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2022-08-31", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-10-15", "last_synced_at": "2026-10-15T22:23:04.573Z", "location_count": 2, "location_summary": "Orlando, Florida • Fort Wayne, Indiana", "locations": [ { "city": "Orlando", "state": "Florida" }, { "city": "Fort Wayne", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT05852457" }, { "nct_id": "NCT05478707", "title": "Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetes Mellitus, Type 1", "Endothelial Dysfunction" ], "interventions": [ { "name": "Dulaglutide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AdventHealth Translational Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 47, "start_date": "2023-10-05", "completion_date": "2028-07-30", "has_results": false, "last_update_posted_date": "2026-10-15", "last_synced_at": "2026-10-17T23:08:56.618Z", "location_count": 1, "location_summary": "Orlando, Florida", "locations": [ { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05478707" }, { "nct_id": "NCT07816367", "title": "A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Migraine" ], "interventions": [ { "name": "Elismetrep", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "TriGemX Bio, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 1500, "start_date": "2026-10-02", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-10-14", "last_synced_at": "2026-10-29T10:47:16.274Z", "location_count": 72, "location_summary": "Glendale, Arizona • Phoenix, Arizona • Little Rock, Arkansas + 64 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Canoga Park", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07816367" }, { "nct_id": "NCT07610473", "title": "A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Major Depressive Disorder (MDD)" ], "interventions": [ { "name": "DT-101", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Draig Therapeutics Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 118, "start_date": "2026-05-14", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-10-14", "last_synced_at": "2026-10-16T01:02:34.130Z", "location_count": 23, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Bellflower, California + 17 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Bellflower", "state": "California" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Lafayette", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07610473" }, { "nct_id": "NCT07609914", "title": "A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Acute Treatment of Migraine" ], "interventions": [ { "name": "Rimegepant", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 400, "start_date": "2026-05-28", "completion_date": "2028-06-07", "has_results": false, "last_update_posted_date": "2026-10-14", "last_synced_at": "2026-10-15T07:17:55.286Z", "location_count": 21, "location_summary": "Canoga Park, California • Fresno, California • Los Angeles, California + 16 more", "locations": [ { "city": "Canoga Park", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07609914" }, { "nct_id": "NCT07590934", "title": "Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Metastatic Prostate Cancer" ], "interventions": [ { "name": "AZD2265 (FPI-2265)", "type": "DRUG" }, { "name": "AZD2287 (Imaging agent)", "type": "DRUG" }, { "name": "Docetaxel", "type": "DRUG" }, { "name": "Palacaparib (AZD9574)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "MALE", "summary": "18 Years to 99 Years · Male only" }, "enrollment_count": 152, "start_date": "2026-06-03", "completion_date": "2029-09-25", "has_results": false, "last_update_posted_date": "2026-10-14", "last_synced_at": "2026-10-16T13:54:24.608Z", "location_count": 12, "location_summary": "Duarte, California • Encino, California • South Pasadena, California + 9 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "South Pasadena", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07590934" }, { "nct_id": "NCT07205718", "title": "A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Advanced or Metastatic Solid Tumors" ], "interventions": [ { "name": "TAK-188", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 273, "start_date": "2025-11-19", "completion_date": "2029-12-21", "has_results": false, "last_update_posted_date": "2026-10-14", "last_synced_at": "2026-10-14T18:21:03.848Z", "location_count": 15, "location_summary": "Santa Monica, California • New Haven, Connecticut • Orlando, Florida + 12 more", "locations": [ { "city": "Santa Monica", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Orlando", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT07205718" } ] }